Study title: Azathioprine maintains first remission in newly diagnosed pediatric Crohn's disease.Jaspers GJ, Verkade HJ, Escher JC, de Ridder L, Taminiau JA, Rings EH. Inflamm Bowel Dis. 2006 Sep;12(9):831-6.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Immune System Diseases | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: Azathioprine | |||||
ATC code: L04AX01 | |||||
Document link: | |||||
Document date: 2015-04-10 | |||||
Study number: PMID: 16954801 | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |